Ken Griffin Aura Biosciences, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2025 May 15, 2025	SELL	$5.86 - $8.45 $1,758 - $2,535	-300 Reduced 4.48%	6,400 $37,000
Q4 2024 Feb 14, 2025	BUY	$8.11 - $11.74 $16,219 - $23,480	2,000 Added 42.55%	6,700 $55,000
Q3 2024 Nov 14, 2024	BUY	$6.9 - $10.36 $20,010 - $30,044	2,900 Added 161.11%	4,700 $41,000
Q2 2024 Aug 14, 2024	BUY	$6.81 - $7.89 $2,042 - $2,367	300 Added 20.0%	1,800 $13,000
Q1 2024 May 15, 2024	SELL	$7.09 - $9.24 $4,254 - $5,544	-600 Reduced 28.57%	1,500 $11,000
Q4 2023 Feb 14, 2024	BUY	$7.02 - $11.98 $7,721 - $13,178	1,100 Added 110.0%	2,100 $18,000
Q2 2023 Aug 14, 2023	BUY	$8.51 - $13.33 $8,510 - $13,330	1,000 New	1,000 $12,000

105

51.5M

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $175M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.